Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hao Wu has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Oral administration of Lactobacillus kefiri Fanghua reduces immune senescence and aging phenotypes

    by Zhenyi Qiao, Yilin Zhang, Huahua Liu, Hong Zou, Qinglian Xie, Jiashu Liu, Huanchang Zhang, Taotao Liu, Zhenmin Liu, Weiwei Qi, et al.

    It has been suggested that immune senescence contributes to the aging of solid organs and that blocking immune senescence can alleviate the aging of organs. Aging is a systemic physiological change. It is currently difficult to achieve the goal of long-term delaying aging through drugs. Improving immunity and delaying aging through probiotics is a feasible research direction. Here, we first screened for a strain of Lactobacillus kefiri Fanghua (L. kefiri-FH) derived from Tibetan kefir and confirmed its function in restoring immunosuppression. Spleen weight, thymus weight, and whole blood cells were restored. The expression of PD-1, P16ink4a, and senescence-associated secretory phenotype (SASP)-related genes in the spleen and thymus was decreased. Second, we further confirmed the phenotype of L. kefiri-FH in improving solid organ function in 16-month-old mice as well as prolonging the lifespan of Caenorhabditis elegans. Mechanistically, whole genome sequencing and metabolomic analysis indicated that L. kefiri-FH contained three genes related to bile acid metabolism and increased lithocholic acid (LCA) in the intestine. We also confirmed that LCA increased G-protein-coupled bile acid receptor, Gpbar5 (TGR5) gene expression in dendritic cells (DCs) and inhibited the induction of Th1 and Th17 cells. Overall, our findings establish a causal relationship between the intestinal microenvironment, immune senescence, and solid organ aging, suggesting a way to regulate the intestinal microenvironment through diet, which thereby improves immune senescence and subsequently reduces solid organ aging.


  • Aerobic Oxidative Hydroxylation of Arylboronic Acids under Visible-Light Irradiation without Metal Catalysts or Additives

    by Hongchen Lu, Yameng Wan, Qiongjin Wang, Yabo Li, Hao Wu, Nana Ma, Zhiguo Zhang, Guisheng Zhang

    Phenols are versatile synthetic intermediates and key structural motifs in many natural products and biologically active compounds. We herein report a visible-light-induced aerobic oxidative hydroxylation of arylboronic acids/pinacol esters using air as oxidant and without using any catalysts and base, etc., additives, providing a green entry to a variety of phenols in a highly efficient and concise fashion. This novel reaction is enabled by photoactivation of an electron donor-acceptor complex, in which THF serves as both the solvent and electron donor. DFT studies indicated that the oxidation process involves a concerted hydrogen abstraction transfer from THF and dehydroxylation of boronic acid undergoing spin crossover from triplet to singlet to produce an active peroxoboronic acid intermidiate. Salient merits of this chemistry include broad substrate scope and excellent functional group tolerance, gram-scale synthesis, and versatile late-stage functionalizations as well as the use of air, visible light, and catalyst- and additive-free conditions. This strategy introduces a novel photoreaction mode with the aid of a solvent, offering a succinct and environmentally sustainable route for synthesizing phenols. The strong practicability and highly efficient access to modifying complex biorelevant molecules bode well for the potential applications of this chemistry in pharmaceutical chemistry.


  • Open Access

    A novel role of the splenic volume in Crohn’s disease: evaluating the efficacy of infliximab

    by Xuan Shi, Jia-Hui Wang, Sheng-Xiang Rao, Tao-Tao Liu, Hao Wu

    Background: A number of patients with Crohn’s disease (CD) suffer from loss of response to infliximab (IFX) therapy. Splenic volume is reported to be enlarged in patients with CD compared to normal individuals. The association between splenic volume and IFX efficacy in CD remains unclear.Methods: We performed a retrospective study of patients with CD who received regular IFX treatment at Zhongshan Hospital, Fudan University, between August 2015 and December 2021. We collected baseline characteristics and clinical features from medical records in the CD database of Zhongshan Hospital. We accurately measured the splenic volume using semi-auto spleen segmentation software, followed by the analysis of splenic volume and IFX efficacy.Results: We included 49 patients with CD receiving IFX treatment, of whom 41 responded to IFX and 8 failed to respond to IFX. Splenic volume, as well as volume adjusted for body mass index (SV/BMI) and body weight (SV/W), was significantly decreased after IFX treatment in responders but increased in non-responders compared to the volume before the treatment. Accordingly, the levels of leukocyte count, platelet count, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were decreased after IFX treatment in responders. Contrarily, the levels of hemoglobin, albumin, and tumor necrosis factor (TNF)-α were elevated in responders. Moreover, both CRP and TNF-α levels were significantly positively correlated with SV/BMI in all patients.Conclusion: Splenic volume, especially SV/BMI and SV/W, was reduced after IFX treatment in CD patients responsive to IFX. SV/BMI was positively correlated with disease activity. Splenic volume is a promising indicator to evaluate IFX efficacy in CD.


  • Open Access

    Teaching and Talent Training Reform of Virtual Reality Course

    by Guowu Yuan, Jiliang Zong, Hao Wu, Wenhua Qian, Yuanyuan Pu, Dan Xu

  • Open Access

    MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT

    by Jie Zhang, Li Cen, Xiaofen Zhang, Chenxi Tang, Yishu Chen, Yuwei Zhang, Mengli Yu, Chao Lu, Meng Li, Sha Li, et al.


  • Metabolic Molecular Diagnosis of Inflammatory Bowel Disease by Synergistical Promotion of Layered Titania Nanosheets with Graphitized Carbon

    by Xufang Hu, Yang Zhang, Chunhui Deng, Nianrong Sun, Hao Wu

    Due to inefficient diagnostic methods, inflammatory bowel disease (IBD) normally progresses into severe complications including cancer. Highly efficient extraction and identification of metabolic fingerprints are of significance for disease surveillance. In this work, we synthesized a layered titania nanosheet doped with graphitized carbon (2D-GC-mTNS) through a simple one-step assembly process for assisting laser desorption ionization mass spectrometry (LDI-MS) for metabolite analysis. Based on the synergistic effect of graphitized carbon and mesoporous titania, 2D-GC-mTNS exhibits good extraction ability including high sensitivity (< 1 fmol µL−1) and great repeatability toward metabolites. A total of 996 fingerprint spectra were collected from hundreds of native urine samples (including IBD patients and healthy controls), each of which contained 1220 m/z metabolite features. Diagnostic model was further established for precise discrimination of patients from healthy controls, with high area under the curve value of 0.972 and 0.981 toward discovery cohort and validation cohort, respectively. The 2D-GC-mTNS promotes LDI-MS to be close to clinical application, with rapid speed, minimum sample consumption and free of sample pretreatment.


  • Genome-wide DNA methylation profiling in differentiating Crohn’s disease from intestinal tuberculosis

    by Hao Wu, Hongchun Liu, Haining Liu, Yanjie Chen, Taotao Liu, Xizhong Shen, Lili Liu

    Background Differential diagnosis of Crohn’s disease (CD) and intestinal tuberculosis (ITB) is still difficult in clinical pratice. DNA methylation has been considered as a favorable area for biomarker exploration and identification. Objective The purpose of the current study was to evaluate DNA methylation changes between CD and ITB. Methods We performed a genome-wide association study to identify differentially methylated positions (DMPs), including 8 CD patients (before the initial of biologics or immunomodulators), 6 ITB patients, and 8 healthy controls (HCs), in whole blood DNA using the Infinium HumanMethylation850 BeadChip. Results Patients in the CD group and ITB group were all observed with hypo-methylated changes compared with HCs. However, the CD group overlaps with the ITB group in DNA methylation, suggesting a stable epigenetic profile between the two diseases. The pathway enrichment analysis showed the alternation in inflammation-related pathway, immune system, and signal transduction. Focused on the DMPs located in the promoter region, further analysis indicated hypermethylation of cg03122532 (5′UTR of KCNJ15) could be a potential CD-specific biomarker. Conclusions We identified specific differential methylation loci related to CD and ITB in blood DNA. DNA metylation as a important epigenetic modification could contribute to the pathogenesis study and biomarker exploration of the diseases.


  • Probing serum N-glycan patterns for rapid and precise detection of Crohn's disease

    by Yonglei Wu, Yijie Chen, Haolin Chen, Chenjie Yang, Xizhong Shen, Chunhui Deng, Nianrong Sun, Hao Wu

    Serum N-glycan patterns from 50 Crohn‘s disease (CD) patients and 50 healthy controls were acquired by a carbon matrix-based platform. According to statistical analysis, eight specific N-glycans revealed remarkable performance for CD diagnosis.


  • Gold‐Doped Covalent Organic Framework Reveals Specific Serum Metabolic Fingerprints as Point of Crohn's Disease Diagnosis

    by Chenjie Yang, Hailong Yu, Xufang Hu, Haolin Chen, Hao Wu, Chunhui Deng, Nianrong Sun

    Currently, most Crohn's disease (CD) patients suffer from serious complications and even surgery due to delayed diagnosis; therefore, point‐of‐care diagnosis of CD is urgently required. In this work, a covalent organic framework@Au (COF‐V@Au) matrix material with excellent laser absorption is prepared, endowing metabolites with great ionization efficiency in laser desorption/ionization mass spectrometry (LDI‐MS) analysis. In addition, the COF‐V@Au matrix possesses 1093 m2 g−1 of large specific surface area and around 2 nm of average pore size, providing abundant sites and efficient structure for metabolite adsorption. Benefiting from high throughput, high sensitivity, and high ionization efficiency of COF‐V@Au assisted LDI‐MS, the extraction of serum metabolic fingerprints of CD group and healthy group is implemented. Moreover, the two groups are successfully distinguished with an area under the curve (AUC) value of 0.984 by establishing an orthogonal partial least squares discriminant analysis (OPLS‐DA) model of Crohn's patients versus healthy controls. Moreover, the expression of 25 features is determined as the prominent metabolic differences between CD patients and the controls. Furthermore, the terminal ileum and ileocolon subtypes of CD are also distinguished from healthy controls with AUC value of 0.989 and 0.991, respectively. Thus, this COF‐V@Au‐assisted LDI‐MS method is expected to be a clinical diagnostic technology in the future.